Acute Respiratory Distress Syndrome is a life threatening condition where the lungs cannot provide the body’s vital organs with enough oxygen.
About the GuARDS study?
GuARDS study aims to provide definitive evidence on whether glucocorticoid treatment saves lives in patients with moderate to severe ARDS.
Active Sites
Patients Randomised
Patients Completed Follow-up
Are you a Patient?
If you are a patient or a relative involved in the GuARDS trial and would like to find out more, please visit our patient information page.
TRIAL Team
The GuARDS team includes doctors, respiratory therapists, nurses, pharmacists, statisticians and scientists from around the world with internationally recognized expertise in treating respiratory failure.
The trial is overseen by a steering committee of experienced clinical trialists, clinicians, and patient representatives.
GuARDS Trial is a global collaboration to generate evidence base for glucocorticoids in ARDS management.
Support and Partners